Sign Out
For treatment of susceptible bacterial infectious diseases as following: 1.Community-acquired pneumonia: Caused by Staphylococcus aureus, Streptococcus pneumoniae including multidrug-resistant strains (MDRSP), Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Chlamydophila pneumoniae (Chlamydia pneumoniae), Legionella pneumophila, Mycoplasma pneumoniae.
2. Nosocomial pneumonia: Caused by methicillin-susceptible Staphylococcus aureus, Pseudomonas aeruginosa, Serratia marcescens, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae, Streptococcus pneumoniae.
In case of infected by Pseudomonas aeruginosa, combination therapy with antipseudomonal β-lactam is recommended to cover bacterial infection appropriately.
3. Skin infections, uncomplicated: e.g. abscesses, furuncles, impetigo, pyoderma, cellulitis, wound infections caused by Staphylococcus aureus, Streptococcus pyogenes.
4. Skin infections, complicated: Caused by methicillin-susceptible Staphylococcus aureus, Enterococcus faecalis, Streptococcus pyogenes, Proteus mirabilis.
5. Urinary tract infections (mild to moderate): Caused by Enterococcus faecalis, Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus saprophyticus.
6. Pyelonephritis (mild to moderate): Caused by Escherichia coli.
7. Acute bacterial sinusitis: Caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis.
8. Acute bacterial exacerbation of chronic bronchitis: Caused by Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis.
9. Chronic bacterial prostatitis: Caused by Escherichia coli, Enterococcus faecalis or Staphylococcus epidermidis.
10. Empirical treatment for community acquired pneumonia.
11. Third-Line therapy for Helicobacter pylori infection: Levofloxacin-based Triple Therapy: Levofloxacin, in combination with other antimicrobial agent and proton pump inhibitor as triple therapy, is indicated for the treatment of patients with gastric ulcer caused by Helicobacter pylori infection and duodenal ulcer disease.
Continue with Google